These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 16338022)

  • 1. Virology of hepatitis B and C viruses and antiviral targets.
    Pawlotsky JM
    J Hepatol; 2006; 44(1 Suppl):S10-3. PubMed ID: 16338022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B and C viruses: molecular identification and targeted antiviral therapies.
    Berenguer M; Wright TL
    Proc Assoc Am Physicians; 1998; 110(2):98-112. PubMed ID: 9542765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coinfection with hepatitis C and B viruses with pre-C mutant].
    Lepilleur B; Schoeny M; Melin P
    Ann Biol Clin (Paris); 2003; 61(3):319-22. PubMed ID: 12805009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing a low-cost drug resistance database for viral hepatitis.
    Kuiken C
    Antivir Ther; 2010; 15(3 Pt B):517-20. PubMed ID: 20516573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.
    Buti M
    IDrugs; 2008 Apr; 11(4):239-41. PubMed ID: 18379952
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-resistant viral hepatitis.
    Wright M; Main J; Thomas HC
    J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
    [No Abstract]   [Full Text] [Related]  

  • 8. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
    Meuleman P; Leroux-Roels G
    Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based and animal models for hepatitis B and C viruses.
    Schinazi RF; Ilan E; Black PL; Yao X; Dagan S
    Antivir Chem Chemother; 1999 May; 10(3):99-114. PubMed ID: 10431609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C viruses.
    Shakya N; Vedi S; Liang C; Agrawal B; Tyrrell DL; Kumar R
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6475-80. PubMed ID: 22985854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of hepatitis virus B and C.
    Dehesa-Violante M; Nuñez-Nateras R
    Arch Med Res; 2007 Aug; 38(6):606-11. PubMed ID: 17613351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of drug resistance in hepatitis viruses B and C].
    Yotsuyanagi H; Koike K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():493-6. PubMed ID: 17455669
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
    Cristina J; del Pilar Moreno M; Moratorio G
    Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis B and C virus mutants. Clinical and therapeutical implications].
    Andreu J; Lissen E
    Gastroenterol Hepatol; 1995 Apr; 18(4):180-5. PubMed ID: 16541565
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunology of hepatitis B virus and hepatitis C virus infection.
    Rehermann B; Nascimbeni M
    Nat Rev Immunol; 2005 Mar; 5(3):215-29. PubMed ID: 15738952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
    De Mitri MS; Cassini R; Morsica G; Bagaglio S; Andreone P; Loggi E; Muratori P; Bernardi M
    J Viral Hepat; 2006 Sep; 13(9):574-81. PubMed ID: 16907843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.